microarray News
-
Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform
The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. Recently, CD Genomics announced the launch of the Microarray Data Analysis service to help scientists discover the biological ...
By CD Genomics
-
Agilent Introduces CGH+SNP cancer microarrays and Cytogenomics software for cancer research
Agilent Technologies Inc., (NYSE: A) today introduced SurePrint G3 CGH+SNP cancer catalog microarrays, addressing the growing need of researchers to detect both copy number and copy-neutral aberrations in cancer tissue samples in the same experiment. The new microarray release is accompanied by the release of Agilent CytoGenomics 2.0 software, which now includes support for CGH+SNP analysis of ...
-
Five-Nation breast cancer study chooses agilent technologies microarrays as primary genomic screening tool
Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression microarrays and associated instruments for a major study of breast cancer in five Latin American nations. The researchers will use the microarrays over three years to study gene-expression profiles of 3,000 women with Stage 2 and Stage ...
-
Agilent Technologies Launches Updated Gene Expression Microarrays for Human, Mouse and Rat Models
Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide up-to-date tools for researchers to investigate expression patterns on a highly accessible platform. Agilent developed the updates to its flagship ...
-
Agilent Technologies releases new cytogenetics software, providing complete solution for researchers
Agilent Technologies Inc. (NYSE: A) today introduced Agilent CytoGenomics 1.5 software. This analytical tool gives researchers the ability to streamline their analysis by querying the in-house CytoGenomic database and external databases. The software is designed for easy data interpretation and simple report generation. Agilent provides the most accepted microarray platform for cytogenetics, and ...
-
Agilent Technologies Joins Forces with Baylor College of Medicine to Provide Customized CGH Microarrays for Cancer, Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable ...
-
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, proudly announces an extensive portfolio of Nervous System Tissue Microarrays designed to support neuroscience research. This comprehensive collection provides researchers with a unique resource to study various neurological conditions and accelerate their investigations into neurological ...
-
Agilent Technologies, Cell Line Genetics Collaborate on High-Throughput Cell-Line Characterization Services for Regenerative Medicine, Cancer Researchers
Agilent Technologies Inc. (NYSE: A) today announced a collaboration with Cell Line Genetics, Inc., a leading provider of cell-line characterization and quality assurance services. CLG will develop high-throughput, genomic characterization workflows to confirm and monitor the integrity of cell lines for translational and regenerative medicine research. The workflows will be based upon Agilent's ...
-
CD Genomics Introduces Professional and Mature Long Amplicon Analysis Service
CD Genomics is a world-leading genomics services company that continues to innovate in high throughput sequencing services for the genomics industry, as well as genotyping, bioinformatics, microarrays, and more. The company launched its Long Amplicon Analysis Service, intending to help simplify project complexity by eliminating additional testing. The correct genome phasing of genetic ...
By CD Genomics
-
Agilent Technologies SureSelect Target Enrichment Now Available for Ion Proton Next-Generation Sequencing Systems
Agilent Technologies Inc. (NYSE: A) today introduced a new SureSelect target enrichment solution that allows Ion Proton users to realize the full power of their next-generation sequencers with the industry's leading human exome and custom DNA target enrichment solutions. SureSelect target enrichment is now available for all major sequencing platforms, enabling researchers to achieve the ...
-
Agilent Technologies Expands Catalog of SureFISH Break-Apart Probes
Agilent Technologies Inc. (NYSE: A) today introduced SureFISH ALK, ROS1 and RET break-apart translocation probes, expanding its offering of oligonucleotide-based fluorescent in situ hybridization (FISH) products. Agilent now offers more than 450 FISH probes The majority of FISH probes available on the market use BAC technology. BAC probes target repeat regions, and probe choices are limited by ...
-
Population Diagnostics, Inc. and The Hospital for Sick Children Discover Novel Genetic Variants Associated with Autism Spectrum Disorder
Peer-Reviewed Findings Provide Medically Relevant Content for Early Detection Pre-symptomatic Diagnostics for Autism as well as New Insights into Drug Discovery Study Demonstrates Potential of Population Diagnostics' Gene Discovery Platform MELVILLE, NY— (Business Wire 12/10/2012) Population Diagnostics, Inc. ("PDx"), a private company with a novel approach for systematically uncovering ...
-
CD Genomics RNA-Solutions Platform Announces the Launch of Nanopore Direct RNA Sequencing
The RNA Solutions platform offers services to revolutionize RNA study, targeting both coding and non-coding RNAs of different physiological functions. Scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. The company has recently launched the Nanopore direct RNA sequencing service for identifying new genes, transcripts, and alternative ...
By CD Genomics
-
CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing
CD Genomics is a world-leading genomics services company that continues to innovate in sequencing solutions for the genomics industry, covering genotyping, library construction, bioinformatics, microarrays, mutagenesis analysis, and more. CD Genomics is pleased to offer whole exome sequencing services, which can help scientists discover disease-related mutation sites more accurately. Exomes are ...
By CD Genomics
-
NIH Study Offers Insight into Why Cancer Incidence Increases with Age
The accumulation of age-associated changes in a biochemical process that helps control genes may be responsible for some of the increased risk of cancer seen in older people, according to a National Institutes of Health study. Scientists have known for years that age is a leading risk factor for the development of many types of cancer, but why aging increases cancer risk remains unclear. ...
-
CD ComputaBio Announces the Launch of IPA Analysis Service to Assist Drug Development
Recently, CD ComputaBio, a world-renowned computational biology services provider, announced the addition of IPA analysis service to all of its businesses. All along, the team of CD ComputaBio has been committed to using their accumulated knowledge and experience in computational biology for many years to continuously expand its services so as to help scientists around the world achieve ...
-
m5C Profiling Services Now Available by CD Genomics`s RNA Solutions Platform
RNA Solutions is the platform that offers services on the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The CD Genomics scientists are ready to help detect various types of RNA via meticulous and integrative approaches. These days, the product manager of CD Genomics announced the m5C profiling services to help researchers deeply ...
By CD Genomics
-
Thermo Fisher Scientific Launches Axiom Microbiome Array for Research
Thermo Fisher Scientific, the world leader in serving science, recently launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of archaea, bacteria, fungi, protozoa and viruses in human and non-human samples. Developed in collaboration with the Lawrence Livermore National Laboratory (LLNL), the array is designed to increase the understanding of microorganisms, while ...
-
Meet CD Genomics at the SITC 37th Annual Meeting
CD Genomics, a world-leading company in genomic services, today announced that members of its management team would participate in the 37th Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in Boston, MA, November 8-12, 2022. Details for the 37th Annual Meeting & Pre-Conference Programs (SITC 2022) The 37th Annual Meeting & Pre-Conference Programs (SITC 2022) provides a ...
By CD Genomics
-
CD Genomics MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics ...
By CD Genomics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you